Clinical Trial Update: Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fostamatinib versus placebo in Asian patients with rheumatoid arthritis; the study was terminated and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-04-07